Inventor · disambiguated record
Jeffrey D. Lee
Also filed as: LEE JEFFREY D
8 granted patents·6 pending applications·61 citations·filing 2014–2022
84Inventor score
Files withREGENERON PHARMA14
Top patents by PatentIndex Score
14 records- 0198US10385359B2Targeted modification of rat genomeREGENERON PHARMA·Filed 2017·Granted Aug 20, 2019·29 cites·39 claims
- 0298US10329582B2Genetic modification of ratsREGENERON PHARMA·Filed 2016·Granted Jun 25, 2019·25 cites·37 claims
- 0393US10975390B2Targeted modification of rat genomeREGENERON PHARMA·Filed 2019·Granted Apr 13, 2021·4 cites·46 claims
- 0488US10894965B2Genetic modification of ratsREGENERON PHARMA·Filed 2019·Granted Jan 19, 2021·2 cites·39 claims
- 0578US12037596B2Targeted modification of rat genomeREGENERON PHARMA·Filed 2021·Granted Jul 16, 2024·0 cites·5 claims
- 0676US12065661B2Genetic modification of ratsREGENERON PHARMA·Filed 2020·Granted Aug 20, 2024·0 cites·21 claims
- 0776US11419318B2Genetically modified rat comprising a humanized TRKB locusREGENERON PHARMA·Filed 2018·Granted Aug 23, 2022·1 cites·9 claims
- 0871US12396444B2Mouse comprising a humanized TRKB locusREGENERON PHARMA·Filed 2022·Granted Aug 26, 2025·0 cites·14 claims
- 0968US2014310828A1Targeted modification of rat genomeREGENERON PHARMA·Filed 2014·Application pending·0 cites
- 1063US2016060657A1Methods and compositions for the targeted modification of a genomeREGENERON PHARMA·Filed 2015·Application pending·0 cites
- 1162US2014309487A1Targeted modification of rat genomeREGENERON PHARMA·Filed 2014·Application pending·0 cites
- 1262US2016108360A1Genetic modification of ratsREGENERON PHARMA·Filed 2015·Application pending·0 cites
- 1361US2014235933A1Genetic modification of ratsREGENERON PHARMA·Filed 2014·Application pending·0 cites
- 1452US2022053741A1Complement Factor H Gene Knockout Rat as a Model of C3 GlomerulopathyREGENERON PHARMA·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeffrey D. Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →